Neoplasm
Not recruitingStudy of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
Italy- Participants:18–64 years · 65+ years
- Substances:Olaparib
Rare diseases
Investigational molecules
Locations
Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
ItalyStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
ItalyStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
ItalyStudy on High-Dose Vitamin C with Ipilimumab and Nivolumab for Patients with Colorectal Cancer
ItalyStudy on the Effects of Tildacerfont and Hydrocortisone in Adults with Classic Congenital Adrenal Hyperplasia
ItalyStudy on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ItalyStudy of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ItalyStudy on the Effects of Dimethyl Fumarate for Patients with Friedreich's Ataxia
ItalyStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
ItalyStudy on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides
ItalyStudy on Ketotifen Eye Drops for Treating Seasonal Allergic Conjunctivitis in Patients
ItalyStudy on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.